Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 2
1994 1
1995 2
1996 2
1997 3
1998 5
1999 8
2000 5
2001 2
2002 5
2003 5
2004 1
2005 3
2006 2
2007 2
2008 7
2009 5
2010 8
2011 15
2012 15
2013 22
2014 16
2015 17
2016 12
2017 9
2018 16
2019 15
2020 18
2021 21
2022 13
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Whole-genome characterization of chemoresistant ovarian cancer.
Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group; Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD. Patch AM, et al. Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Nature. 2015. PMID: 26017449
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.
Bandara V, Foeng J, Gundsambuu B, Norton TS, Napoli S, McPeake DJ, Tyllis TS, Rohani-Rad E, Abbott C, Mills SJ, Tan LY, Thompson EJ, Willet VM, Nikitaras VJ, Zheng J, Comerford I, Johnson A, Coombs J, Oehler MK, Ricciardelli C, Cowin AJ, Bonder CS, Jensen M, Sadlon TJ, McColl SR, Barry SC. Bandara V, et al. Among authors: oehler mk. Nat Commun. 2023 Sep 8;14(1):5546. doi: 10.1038/s41467-023-41338-y. Nat Commun. 2023. PMID: 37684239 Free PMC article.
Endometrial cancer.
Ryan AJ, Susil B, Jobling TW, Oehler MK. Ryan AJ, et al. Among authors: oehler mk. Cell Tissue Res. 2005 Oct;322(1):53-61. doi: 10.1007/s00441-005-1109-5. Epub 2005 Nov 3. Cell Tissue Res. 2005. PMID: 15947972 Review.
Postmenopausal vulval disease.
Olsson A, Selva-Nayagam P, Oehler MK. Olsson A, et al. Among authors: oehler mk. Menopause Int. 2008 Dec;14(4):169-72. doi: 10.1258/mi.2008.008030. Menopause Int. 2008. PMID: 19037066 Review.
Menorrhagia: an update.
Oehler MK, Rees MC. Oehler MK, et al. Acta Obstet Gynecol Scand. 2003 May;82(5):405-22. doi: 10.1034/j.1600-0412.2003.00097.x. Acta Obstet Gynecol Scand. 2003. PMID: 12752071 Free article. Review.
Mass Spectrometry Analyses of Multicellular Tumor Spheroids.
Acland M, Mittal P, Lokman NA, Klingler-Hoffmann M, Oehler MK, Hoffmann P. Acland M, et al. Among authors: oehler mk. Proteomics Clin Appl. 2018 May;12(3):e1700124. doi: 10.1002/prca.201700124. Epub 2018 Feb 9. Proteomics Clin Appl. 2018. PMID: 29227035 Review.
Sphingolipids as multifaceted mediators in ovarian cancer.
Pitman M, Oehler MK, Pitson SM. Pitman M, et al. Among authors: oehler mk. Cell Signal. 2021 May;81:109949. doi: 10.1016/j.cellsig.2021.109949. Epub 2021 Feb 8. Cell Signal. 2021. PMID: 33571664 Review.
State of the art of 2D DIGE.
Arentz G, Weiland F, Oehler MK, Hoffmann P. Arentz G, et al. Among authors: oehler mk. Proteomics Clin Appl. 2015 Apr;9(3-4):277-88. doi: 10.1002/prca.201400119. Epub 2015 Feb 19. Proteomics Clin Appl. 2015. PMID: 25400138 Review.
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G, Clamp A, Farley J, Iyer G, Ray-Coquard I, Monk BJ. Grisham RN, et al. Among authors: oehler mk. Clin Cancer Res. 2023 Oct 13;29(20):4068-4075. doi: 10.1158/1078-0432.CCR-23-0621. Clin Cancer Res. 2023. PMID: 37581616 Free PMC article.
248 results